Why Are Over 2 Million Americans Each Year Experiencing So Many Adverse Drug Side Effects?
Prescription drugs help treat medical conditions worldwide, but when misused or from reasons outside their control, these same drugs can cause great harm and even death. According to the FDA, more than 2.7 million adverse events from drugs affect Americans every year. It is well known that the third leading cause of death, following heart disease and cancer in the United States and Europe, is from adverse drug effects and other medical errors. Think about that for a minute. Properly prescribed medications that are supposed to help, are killing people instead. Of those deaths, around half take their drugs correctly; errors in dosing or drug contraindications make up the other half.
More people than ever are taking medications. Over 6.47 billion prescriptions are dispensed annually to over 131 million people. The average number of prescriptions taken is four. Around 66% of Americans take at least one drug, with 13% or more taking five or more. There are between 10 and 100 different side effects in 69% of prescription drugs. Less than 10 side effects occur in only 9% of drugs, while drugs with more than 100 side effects occur in 22%.
Other reasons deaths result from prescription drugs include: inept drug regulations; corruption of the scientific evidence about drugs; bribery of doctors; and lies in drug marketing. Medication errors include environmental, physical, and psychological causes. Environmental causes include grabbing the wrong medication for a patient, the pharmacy dispenses the wrong drug, or incorrectly prepares the dosage. Physical causes include miscalculating, mistyping, or misreading a dosage. Whereas psychological causes might include cognitive lapse or fatigue.
Meeting the needs of patients has taken a back seat to meeting the needs of the drug companies.
The pharmaceutical industry has corrupted the practice of medicine through its influence over what drugs are developed, how they are tested, and how medical knowledge is created. Since 1906, heavy commercial influence has compromised congressional legislation to protect the public from unsafe drugs. The authorization of user fees in 1992 has turned drug companies into the FDA's prime clients, deepening the regulatory and cultural capture of the agency. Industry has demanded shorter average review times and, with less time to thoroughly review evidence, increased hospitalizations and deaths have resulted. Unless this corruption of regulatory intent is reversed, the situation will continue to deteriorate.
There are safe, proven, evidence-based drugs now available. ImunStem showed positive medical results for patients with Serious or Life-threatening conditions or diseases, which prompted the US Food and Drug Administration (FDA) to move forward so patients could be provided treatment that was not otherwise available to them from their physicians/doctors. These 100% plant-based drugs have no known adverse side-effects, patients are not dying from taking them but instead are healing quickly with positive results and there are no contraindications with other drugs.
ImunStem stimulates the immune system throughout the body. ImunStem also helps blood flow through the system, especially in difficult regions such as body capillaries. ImunStem is a highly mobile compound that has been shown as a central nervous system and immune system stimulant. ImunStem can act alone safely or with other medical therapies to maximize efficacy and produce faster and lasting benefits to treat serious or life-threatening conditions or diseases by supporting immune system function. Physicians have observed that using ImunStem provokes a significant response, i.e., a reduction in symptoms in patients with these diseases: autism, Alzheimer’s, neuropathy, chronic lymphocytic leukemia, multiple sclerosis, Parkinson’s, schizoaffective disorder, fragile-X syndrome, and a significant decrease of side-effects to chemotherapy for cancer. ImunStem has been shown to help reduce the loss of blood from surgical the wound and menstrual periods (shorter and lighter periods)
Serious or Life-threatening conditions or diseases are defined as: a condition where the likelihood of death is high unless the course of the disease is interrupted and conditions or diseases with potentially fatal outcomes may occur, where the end point of clinical analysis is survival needs to be addressed. The criteria of life-threatening do not require the condition to be immediately life-threatening or to immediately result in death. Rather, the patients must be in a life-threatening situation requiring intervention before review at a convened Instructional Review Board meeting is feasible. ImunStem has been given by licensed physicians/doctors to patients suffering from Serious or Life-threatening conditions or diseases. ImunStem does not have harmful side effects and is very safe to use. It has shown efficacy and is admired by physicians/doctors who have administered ImunStem and have observed an improvement in patient outcomes, including improved quality of life.
References
Tieu, H. S., & Loeffler, M. F. (2022). FDA approves First Dietary Supplement under new drug application with the indication of serious or life-threatening illnesses. Pharmacology &Amp; Pharmacy, 13(12), 529–544. https://doi.org/10.4236/pp.2022.1312038
Light DW, Lexchin J, Darrow JJ. Institutional corruption of pharmaceuticals and the myth of safe and effective drugs. J Law Med Ethics. 2013 Fall;41(3):590-600. doi: 10.1111/jlme.12068. PMID: 24088149.
Tieu, Huu S., et al. “Huu S. TIEU Request for FDA to Establish Regenerating Human Cells as Law on December 13, 2016 President Barack H. Obama Singed the 21st Century CURES Act into FDA Regulation and Law.” Open Journal of Regenerative Medicine, vol. 11, no. 03, Sept. 2022, pp. 55–62,
https://doi.org/10.4236/ojrm.2022.113004. Accessed 11 Feb. 2023.
Jacobson, Anne. "Prescription Drug Statistics 2021." The Checkup, 1 Sept. 2021, www.singlecare.com/blog/news/prescription-dru
Gøtzsche PC. Our prescription drugs kill us in large numbers. Pol Arch Med Wewn. 2014;124(11):628-34. doi: 10.20452/pamw.2503. Epub 2014 Oct 30. PMID: 25355584.